Literature DB >> 7208558

Drug preference and mood in humans: repeated assessment of d-amphetamine.

C E Johanson, E H Uhlenhuth.   

Abstract

Ten normal human volunteers participated in 3 identical choice experiments comparing 5 mg d-amphetamine and placebo. Each experiment consisted of 9 sessions. During the first 4 sessions of each experiment, subjects received alternatively drug or placebo. During the next 5 sessions, they were given a choice between amphetamine and placebo. Subjective effects were assessed using the Profile of Mood States (POMS) before drug was taken and 1, 3 and 6 hrs later. Subjects chose amphetamine an average of 4.0, 3.2 and 2.1 times out of 5 during each of the three experiments, in that order. Compared to placebo, amphetamine produced changes in mood as measured by the POMS including increased Vigor, Elation, Arousal and Positive Mood. Mood changes produced by amphetamine were similar across all three experiments despite the decrease in drug preference, suggesting the independence of these two measures. The results are discussed in terms of developing methods for predicting the abuse potential of psychotropic drugs.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7208558     DOI: 10.1016/0091-3057(81)90237-9

Source DB:  PubMed          Journal:  Pharmacol Biochem Behav        ISSN: 0091-3057            Impact factor:   3.533


  14 in total

1.  Cannabinoid modulation of subgenual anterior cingulate cortex activation during experience of negative affect.

Authors:  Christine A Rabinak; Chandra Sekhar Sripada; Mike Angstadt; Harriet de Wit; K Luan Phan
Journal:  J Neural Transm (Vienna)       Date:  2011-12-11       Impact factor: 3.575

2.  A within-subject assessment of the discriminative stimulus and reinforcing effects of self-administered cocaine in rhesus monkeys.

Authors:  Jennifer L Martelle; Michael A Nader
Journal:  Psychopharmacology (Berl)       Date:  2008-09-21       Impact factor: 4.530

3.  Amphetamine self-administration by humans: modulation by contingencies associated with task performance.

Authors:  S D Comer; M Haney; R W Foltin; M W Fischman
Journal:  Psychopharmacology (Berl)       Date:  1996-09       Impact factor: 4.530

4.  Relationship between oral D-amphetamine self-administration and ratings of subjective effects: do subjective-effects ratings correspond with a progressive-ratio measure of drug-taking behavior?

Authors:  B Levi Bolin; Anna R Reynolds; William W Stoops; Craig R Rush
Journal:  Behav Pharmacol       Date:  2013-09       Impact factor: 2.293

5.  The acetylcholinesterase inhibitor rivastigmine does not alter total choices for methamphetamine, but may reduce positive subjective effects, in a laboratory model of intravenous self-administration in human volunteers.

Authors:  R De La Garza; J J Mahoney; C Culbertson; S Shoptaw; T F Newton
Journal:  Pharmacol Biochem Behav       Date:  2008-01-22       Impact factor: 3.533

6.  Reinforcing properties of oral delta 9-tetrahydrocannabinol, smoked marijuana, and nabilone: influence of previous marijuana use.

Authors:  J H Mendelson; N K Mello
Journal:  Psychopharmacology (Berl)       Date:  1984       Impact factor: 4.530

7.  Assessment of dependence potential of drugs in humans using multiple indices.

Authors:  C E Johanson; K Kilgore; E H Uhlenhuth
Journal:  Psychopharmacology (Berl)       Date:  1983       Impact factor: 4.530

Review 8.  Striatal ups and downs: their roles in vulnerability to addictions in humans.

Authors:  Marco Leyton; Paul Vezina
Journal:  Neurosci Biobehav Rev       Date:  2013-01-16       Impact factor: 8.989

9.  The discriminative stimulus and subjective effects of d-amphetamine in humans.

Authors:  L D Chait; E H Uhlenhuth; C E Johanson
Journal:  Psychopharmacology (Berl)       Date:  1985       Impact factor: 4.530

Review 10.  Conditioned cues and the expression of stimulant sensitization in animals and humans.

Authors:  Paul Vezina; Marco Leyton
Journal:  Neuropharmacology       Date:  2008-07-09       Impact factor: 5.250

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.